Pomanda estimates the enterprise value of PHARMACO FOUNDATION LTD at £34.7k based on a Turnover of £63.3k and 0.55x industry multiple (adjusted for size and gross margin).
pharmaco foundation ltdEstimated Valuation
£125.9k
Pomanda estimates the enterprise value of PHARMACO FOUNDATION LTD at £125.9k based on an EBITDA of £31.4k and a 4.01x industry multiple (adjusted for size and gross margin).
pharmaco foundation ltdEstimated Valuation
£881.9k
Pomanda estimates the enterprise value of PHARMACO FOUNDATION LTD at £881.9k based on Net Assets of £413.4k and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmaco Foundation LtdOverview
Pharmaco Foundation Ltd is a live company located in birmingham, B7 5AR with a Companies House number of 07016271. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in September 2009, it's largest shareholder is
unknown.
Pharmaco Foundation Ltd is a established,
micro sized company, Pomanda has estimated its turnover at
£63.3k with
declining
growth in recent years.
Pomanda's financial health check has awarded Pharmaco Foundation Ltd a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating4.5out of 5
4 Strong
2 Regular
5 Weak
Size
annual sales of £63.3k, make it smaller than the average company (£3.7m)
£63.3k - Pharmaco Foundation Ltd
£3.7m - Industry AVG
Growth
3 year (CAGR) sales growth of -7%, show it is growing at a slower rate (8.2%)
-7% - Pharmaco Foundation Ltd
8.2% - Industry AVG
Production
with a gross margin of 38.1%, this company has a comparable cost of product (38.1%)
38.1% - Pharmaco Foundation Ltd
38.1% - Industry AVG
Profitability
an operating margin of 46.3% make it more profitable than the average company (5.7%)
46.3% - Pharmaco Foundation Ltd
5.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (22)
1 - Pharmaco Foundation Ltd
22 - Industry AVG
Pay Structure
on an average salary of £46.5k, the company has an equivalent pay structure (£46.5k)
£46.5k - Pharmaco Foundation Ltd
£46.5k - Industry AVG
Efficiency
resulting in sales per employee of £63.3k, this is less efficient (£145.9k)
£63.3k - Pharmaco Foundation Ltd
£145.9k - Industry AVG
Debtor Days
it gets paid by customers after 81 days, this is later than average (36 days)
81 days - Pharmaco Foundation Ltd
36 days - Industry AVG
Creditor Days
its suppliers are paid after 47 days, this is slower than average (33 days)
47 days - Pharmaco Foundation Ltd
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmaco Foundation Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 603 weeks, this is more cash available to meet short term requirements (26 weeks)
603 weeks - Pharmaco Foundation Ltd
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 3%, this is a lower level of debt than the average (58.8%)
3% - Pharmaco Foundation Ltd
58.8% - Industry AVG
PHARMACO FOUNDATION LTD financials
EXPORT
Pharmaco Foundation Ltd's latest turnover from March 2024 is £63.3 thousand and the company has net assets of £413.4 thousand. According to their latest financial statements, we estimate that Pharmaco Foundation Ltd has 1 employee and maintains cash reserves of £150 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Sep 2011
Sep 2010
Turnover
63,316
72,955
70,650
78,951
68,200
59,306
65,183
67,237
72,919
67,056
48,077
26,173
23,407
43,004
Other Income Or Grants
Cost Of Sales
39,175
44,717
43,830
49,505
42,256
36,909
40,407
41,113
45,488
42,448
30,648
16,591
14,350
25,751
Gross Profit
24,141
28,238
26,820
29,446
25,944
22,397
24,776
26,124
27,431
24,608
17,429
9,582
9,057
17,253
Admin Expenses
-5,158
-18,318
-9,276
-13,074
-14,243
-25,701
-18,560
-37,726
-30,385
-35,648
-12,525
20,969
-7,370
11,975
Operating Profit
29,299
46,556
36,096
42,520
40,187
48,098
43,336
63,850
57,816
60,256
29,954
-11,387
16,427
5,278
Interest Payable
90
30
161
40
63
Interest Receivable
Pre-Tax Profit
27,540
41,525
29,662
34,475
32,574
39,145
35,246
51,145
46,378
47,790
23,260
-11,294
12,192
3,807
Tax
Profit After Tax
27,540
41,525
29,662
34,475
32,574
39,145
35,246
51,145
46,378
47,790
23,260
-11,294
12,192
3,807
Dividends Paid
Retained Profit
27,540
41,525
29,662
34,475
32,574
39,145
35,246
51,145
46,378
47,790
23,260
-11,294
12,192
3,807
Employee Costs
46,514
44,767
42,253
40,167
39,774
38,568
36,365
35,565
35,655
35,509
35,267
34,789
36,269
35,321
Number Of Employees
1
1
1
1
1
1
1
1
1
1
1
1
1
1
EBITDA*
31,399
48,656
38,196
44,620
42,287
50,198
45,436
65,950
59,916
62,356
29,954
-11,387
16,427
5,278
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Sep 2011
Sep 2010
Tangible Assets
258,894
260,994
263,094
265,194
267,294
269,394
271,494
273,594
275,694
277,794
258,894
258,894
244,065
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
258,894
260,994
263,094
265,194
267,294
269,394
271,494
273,594
275,694
277,794
258,894
258,894
244,065
Stock & work in progress
Trade Debtors
14,214
368
7,656
2,052
1,061
2,552
1,000
Group Debtors
Misc Debtors
3,275
281
281
281
281
29
3,128
917
48,720
Cash
149,991
132,724
88,915
50,785
31,864
23,739
37,273
33,566
31,715
30,996
64,103
37,268
15,439
3,927
misc current assets
1
total current assets
167,480
133,373
89,196
58,722
34,197
23,740
37,302
33,566
32,776
33,548
68,231
38,185
64,159
3,927
total assets
426,374
394,367
352,290
323,916
301,491
293,134
308,796
307,160
308,470
311,342
327,125
297,079
308,224
3,927
Bank overdraft
Bank loan
Trade Creditors
5,122
1,315
796
2,030
365
509
778
1
3,638
149
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
7,807
7,147
7,114
7,168
20,883
45,465
99,763
133,882
185,559
235,586
295,522
292,225
292,225
120
total current liabilities
12,929
8,462
7,910
9,198
21,248
45,465
100,272
133,882
186,337
235,587
299,160
292,374
292,225
120
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
12,929
8,462
7,910
9,198
21,248
45,465
100,272
133,882
186,337
235,587
299,160
292,374
292,225
120
net assets
413,445
385,905
344,380
314,718
280,243
247,669
208,524
173,278
122,133
75,755
27,965
4,705
15,999
3,807
total shareholders funds
413,445
385,905
344,380
314,718
280,243
247,669
208,524
173,278
122,133
75,755
27,965
4,705
15,999
3,807
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Sep 2011
Sep 2010
Operating Activities
Operating Profit
29,299
46,556
36,096
42,520
40,187
48,098
43,336
63,850
57,816
60,256
29,954
-11,387
16,427
5,278
Depreciation
2,100
2,100
2,100
2,100
2,100
2,100
2,100
2,100
2,100
2,100
Amortisation
Tax
Stock
Debtors
16,840
368
-7,656
5,604
2,333
-29
29
-1,061
-1,491
-1,576
3,211
917
48,720
Creditors
3,807
519
-1,234
1,665
365
-509
509
-778
777
-3,637
3,489
149
Accruals and Deferred Income
660
33
-54
-13,715
-24,582
-54,298
-34,119
-51,677
-50,027
-59,936
3,297
292,225
292,105
120
Deferred Taxes & Provisions
Cash flow from operations
19,026
48,840
44,564
26,966
15,737
-4,580
11,797
14,556
12,157
359
33,529
280,070
259,812
5,398
Investing Activities
capital expenditure
-21,000
-258,894
-244,065
Change in Investments
cash flow from investments
-21,000
-258,894
-244,065
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
15,999
interest
-90
-30
-161
-40
-63
cash flow from financing
-90
-30
15,838
-40
-63
cash and cash equivalents
cash
17,267
43,809
38,130
18,921
8,125
-13,534
3,707
1,851
719
-33,107
26,835
37,268
11,512
3,927
overdraft
change in cash
17,267
43,809
38,130
18,921
8,125
-13,534
3,707
1,851
719
-33,107
26,835
37,268
11,512
3,927
pharmaco foundation ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pharmaco foundation ltd. Get real-time insights into pharmaco foundation ltd's credit score, group structure and payment trends.
Perform a competitor analysis for pharmaco foundation ltd by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in B 7 area or any other competitors across 12 key performance metrics.
pharmaco foundation ltd Ownership
PHARMACO FOUNDATION LTD group structure
Pharmaco Foundation Ltd has no subsidiary companies.
Ultimate parent company
PHARMACO FOUNDATION LTD
07016271
PHARMACO FOUNDATION LTD Shareholders
The sole shareholder of Pharmaco Foundation Ltd is -.
-
-
pharmaco foundation ltd directors
Pharmaco Foundation Ltd currently has 3 directors.
The longest serving directors include
Mr Mushtaq Ismail (May 2011) and
Mr Lyakat Jaffer (Dec 2013).
82990 - Other business support service activities n.e.c.
incorporation date
September 2009
age
16
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
SAJJAD SUMAR
auditor
-
address
unit 4 boultbee business units, nechells place, birmingham, B7 5AR
Bank
-
Legal Advisor
-
pharmaco foundation ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to pharmaco foundation ltd. Currently there are 1 open charges and 0 have been satisfied in the past.
pharmaco foundation ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARMACO FOUNDATION LTD. This can take several minutes, an email will notify you when this has completed.
pharmaco foundation ltdCompanies House Filings - See Documents
